JP4589118B2 - インフルエンザウイルス感染の治療に有用な医薬の調製のためのリスベラトロールの使用 - Google Patents

インフルエンザウイルス感染の治療に有用な医薬の調製のためのリスベラトロールの使用 Download PDF

Info

Publication number
JP4589118B2
JP4589118B2 JP2004549541A JP2004549541A JP4589118B2 JP 4589118 B2 JP4589118 B2 JP 4589118B2 JP 2004549541 A JP2004549541 A JP 2004549541A JP 2004549541 A JP2004549541 A JP 2004549541A JP 4589118 B2 JP4589118 B2 JP 4589118B2
Authority
JP
Japan
Prior art keywords
resveratrol
virus
infection
cells
influenza virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2004549541A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006507295A (ja
JP2006507295A5 (enExample
Inventor
エンリコ・ガラチ
アンナ・テレサ・パラマラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JP2006507295A publication Critical patent/JP2006507295A/ja
Publication of JP2006507295A5 publication Critical patent/JP2006507295A5/ja
Application granted granted Critical
Publication of JP4589118B2 publication Critical patent/JP4589118B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2004549541A 2002-11-06 2003-10-14 インフルエンザウイルス感染の治療に有用な医薬の調製のためのリスベラトロールの使用 Expired - Lifetime JP4589118B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
PCT/IT2003/000626 WO2004041260A1 (en) 2002-11-06 2003-10-14 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections

Publications (3)

Publication Number Publication Date
JP2006507295A JP2006507295A (ja) 2006-03-02
JP2006507295A5 JP2006507295A5 (enExample) 2006-11-24
JP4589118B2 true JP4589118B2 (ja) 2010-12-01

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004549541A Expired - Lifetime JP4589118B2 (ja) 2002-11-06 2003-10-14 インフルエンザウイルス感染の治療に有用な医薬の調製のためのリスベラトロールの使用

Country Status (18)

Country Link
US (1) US8431617B2 (enExample)
EP (1) EP1567137B1 (enExample)
JP (1) JP4589118B2 (enExample)
KR (1) KR101060331B1 (enExample)
AR (1) AR041891A1 (enExample)
AT (1) ATE381929T1 (enExample)
AU (1) AU2003279551A1 (enExample)
CA (1) CA2504872C (enExample)
CY (1) CY1107302T1 (enExample)
DE (1) DE60318327T2 (enExample)
DK (1) DK1567137T3 (enExample)
ES (1) ES2295660T3 (enExample)
IT (1) ITRM20020562A1 (enExample)
MX (1) MXPA05004628A (enExample)
PL (1) PL217628B1 (enExample)
PT (1) PT1567137E (enExample)
TW (1) TWI337863B (enExample)
WO (1) WO2004041260A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2626056A1 (en) * 2005-11-18 2007-05-24 Ares Trading S.A. Interferon in influenza
US8629283B2 (en) * 2008-03-06 2014-01-14 Icahn School Of Medicine At Mount Sinai Compounds that modulate negative-sense, single-stranded RNA virus replication and uses thereof
AU2009313657A1 (en) * 2008-11-04 2010-05-14 Metaproteomics, Llc Phytochemical compositions and methods for activating AMP-kinase
WO2010123527A2 (en) * 2008-12-19 2010-10-28 The Regents Of The University Of California Use of epidermal growth factor inhibitors in the treatment of viral infection
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
US9096585B2 (en) 2010-05-28 2015-08-04 Icahn School Of Medicine At Mount Sinai Antiviral compounds and uses thereof
US9453017B2 (en) * 2011-09-30 2016-09-27 Vanderbilt University Antiviral therapies with phospholipase D inhibitors
PT2952209T (pt) 2014-06-04 2018-05-09 Alfasigma Spa Formulações homogéneas compreendendo ácidos gordos poliinsaturados ómega-3 (n-3 pufa) e resveratrol para administração oral
SI2952180T1 (sl) 2014-06-04 2017-05-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Trdne formulacije, ki vsebujejo resveratrol in polinenasičene maščobne kisline omega-3 (n-3 PUFA)
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
EP4132277B1 (en) * 2020-04-05 2025-11-26 Mong, Michael Systems and methods for treating coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
DE60015568D1 (de) * 1999-08-13 2004-12-09 Univ Maryland Biotech Inst Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür

Also Published As

Publication number Publication date
DE60318327T2 (de) 2008-12-18
JP2006507295A (ja) 2006-03-02
AR041891A1 (es) 2005-06-01
PL377557A1 (pl) 2006-02-06
CA2504872A1 (en) 2004-05-21
PT1567137E (pt) 2008-02-19
TWI337863B (en) 2011-03-01
AU2003279551A1 (en) 2004-06-07
EP1567137B1 (en) 2007-12-26
EP1567137A1 (en) 2005-08-31
PL217628B1 (pl) 2014-08-29
TW200501935A (en) 2005-01-16
DK1567137T3 (da) 2008-04-28
WO2004041260A1 (en) 2004-05-21
ITRM20020562A1 (it) 2004-05-07
US20050239906A1 (en) 2005-10-27
US8431617B2 (en) 2013-04-30
CA2504872C (en) 2011-07-05
DE60318327D1 (de) 2008-02-07
MXPA05004628A (es) 2005-09-08
ATE381929T1 (de) 2008-01-15
ES2295660T3 (es) 2008-04-16
KR101060331B1 (ko) 2011-08-30
CY1107302T1 (el) 2012-11-21
KR20050071627A (ko) 2005-07-07

Similar Documents

Publication Publication Date Title
JP4589118B2 (ja) インフルエンザウイルス感染の治療に有用な医薬の調製のためのリスベラトロールの使用
Cai et al. Inhibition of influenza infection by glutathione
RU2769317C2 (ru) Способы лечения гриппа
Shin et al. Broad‐spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses
RU2524304C2 (ru) Применение соли ацетилсалициловой кислоты для лечения вирусных инфекций
AU2010306840B2 (en) Recombinant human CC10 protein for treatment of influenza
EP4003322A1 (en) Antioxidant and antiviral compositions and methods
US20240293384A1 (en) Methods and compositions for treatment of covid-19
Giannone et al. Berberine inhibitory action against zika and dengue viruses in cell cultures
KR20230021009A (ko) 항바이러스 치료로서의 아젤라스틴
WO2021191904A1 (en) Methods for preventing and treating viral infection
Yang et al. Exploration of the mechanisms of Callicarpa nudiflora Hook. et Arn against influenza A virus (H1N1) infection
CN117717553A (zh) 汉防己甲素用于制备抗流感病毒感染口服混悬液的新用途
KR102434383B1 (ko) 매스틱 검을 유효성분으로 함유하는 항바이러스 조성물
CN109864988B (zh) 佛手柑素和/或蔓荆子黄素的应用和应用其的产品
WO2022205822A1 (zh) 一种抑制新型冠状病毒感染的抗菌肽及其用途
Kirkpatrick et al. Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against viral infections. mBio 9: e00696-18
CN118403075B (zh) 偏钨酸钠在制备治疗或预防流感病毒感染的药物中的应用
Liu et al. Infectious Bronchitis Virus Triggered Caspase-8/Casapase-3/DFNA5-Mediated Pyroptosis in HD11 Cells Via ROS
CN116531509A (zh) 一种基于天然萘醌的药物组合物及应用
RU2695336C1 (ru) Композиция на основе пептида, подавляющего репликацию вируса гриппа А
Chamberlain Pathological Consequences Of Pdi Oxidoreductase Activity On Viral Protein Maturation
CN120053451A (zh) 乙胺嘧啶在制备抗病毒制剂中的应用
Chamberlain et al. PDI INHIBITION ALTERS INFLUENZA NEURAMINIDASE ACTIVITY AND SUBSEQUENT VIRAL PATHOGENESIS IN VIVO
Goulding Calcium dependent host innate immune resistance to influenza A virus infection

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060927

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060927

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100506

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100513

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100531

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100607

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100702

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100810

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100909

R150 Certificate of patent or registration of utility model

Ref document number: 4589118

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130917

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term